Most clinical peptides — BPC-157, CJC-1295, Ipamorelin, AOD-9604, and many others — are not listed on the Australian Register of Therapeutic Goods (ARTG). That doesn't mean they're illegal. It means an Australian doctor has to use a specific TGA pathway to prescribe them lawfully. The most common pathway is the Special Access Scheme, Category B — usually shortened to SAS-B.
SAS-B is a Therapeutic Goods Administration mechanism that lets a registered Australian medical practitioner prescribe an unapproved therapeutic good for an individual patient on a case-by-case basis. The prescriber lodges a notification with the TGA, keeps a clinical record, and carries the clinical responsibility for the decision. You are receiving a medicine, prescribed by a doctor, not a "research chemical".
The alternative is the Authorised Prescriber scheme, where a doctor who has been formally authorised by the TGA for a specific unapproved good can prescribe it without notifying the TGA each time. Both pathways are legitimate; SAS-B is more common for individual patients.
Free guide: Legal Peptides in Australia (2026)
What's legal under TGA SAS-B, which peptides Australian doctors actually prescribe, real costs, and the questions to ask at your consult.
No spam. Unsubscribe any time. See our privacy policy.
What this means for you as a patient: when an AHPRA-registered Australian doctor prescribes a peptide via SAS-B, the prescription is dispensed by a TGA-licensed Australian compounding pharmacy that operates under PIC/S Good Manufacturing Practice. The vial you inject has a chain of custody — pharmaceutical-grade active ingredient, sterile cleanroom compounding, validated potency assay, endotoxin testing on every batch.
What it does NOT mean: SAS-B is not a "loophole" for buying peptides online without a doctor. Importing peptides yourself from offshore "research chemical" vendors remains illegal under the Customs Act regardless of any prescription you might have. The lawful path is doctor → SAS-B notification → Australian compounding pharmacy → you.
If you're considering peptide therapy in Australia, the questions to ask are: is the prescriber AHPRA-registered, is the pathway SAS-B or Authorised Prescriber, and is the dispensing pharmacy TGA-licensed for compounding? If all three answers are yes, you're inside the regulated medical system. If any are unclear, you're not.